stockrowEnveric Biosciences, Inc. (ENVB) vs Exicure, Inc. (XCUR)
- Enveric Biosciences, Inc. ENVB 1.42 +1.43%
- Exicure, Inc. XCUR 0.91 +2.25%
Enveric Biosciences, Inc. and Exicure, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Exicure, Inc. are of similar size ($6.3M and $5.8M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −13.9%. Across the 12 metrics below, Enveric Biosciences, Inc. leads on 6 and Exicure, Inc. on 6.
Valuation
Profitability
| Metric | ENVB | XCUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 80.08% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (168.37%) | (51.96%) |
| Return on assets | (193.53%) | (54.98%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack